| Application no. and date | 15760590.8 (espacenet) (Federated) (European Patent Register), 20150828 | | Patent/reg. no. and date | DK/EP 3191513, 20200624 | | Publication date | 20170719 | | Priority no. and date | US 201462047248 P, 20140908, US 201462091150 P, 20141212, US 201562168007 P, 20150529, US 201562191690 P, 20150713 | | EP pub. no. and date |
EP 3191513 20170719 | | Effective date | | | Applicant/owner | Cephalon LLC, 145 Brandywine Parkway,
West Chester, Pennsylvania 19380 , US | | Applicant ref. no. | 1552790 | | Inventor | BRUSSELLE, Guy, Begonialaan 28
9840 De Pinte, BE,
O'BRIEN, Christopher, 110 Chinaberry Drive
Lafayette Hill, PA 19444, US,
ZANGRILLI, James, 1606 Chestnut Street
Unit 2
Philadelphia, PA 19103, US,
SHAH, Tushar, 124 Hilcrest Road
Flemington, NJ 08022, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07K 16/24 (2006.01) | | Title | ANVENDELSE AF RESLIZUMAB TIL BEHANDLING AF MODERAT TIL SVÆR EOSINOFIL ASTMA | | Int. application no. | US2015047357 | | Int. publication no. | WO2016040007 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
